FDA Warns Unilever and Dr Pepper on Improper Green Tea Statements

The Food and Drug Administration has warned beverage makers Dr Pepper Snapple Group Inc (DPS) and Unilever for making improper statements regarding green tea on product labels and web sites. – Reuters

Create Content With AI

Try TradingView For Free

Risk Our Money Not Yours | Get 50% Off Any Account

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.